7782-87-8O=[PH+][O-].[K+]HBVUHCGNRVSZOO-UHFFFAOYSA-N7782-87-8White hygroscopic crystals
White crystals or granular powder
White opaque crystals or pwder
Very soluble in water
One gram dissolves in 0.6 mL water
Soluble in ethanol
One gram dissolves in 9 mL alcohol, 5 mL boiling alcohol
Decomposed by heat.
When heated to decomposition it emits very toxic fumes of /phosphorous oxides/ and potassium oxide.
When strongly heated it decomposes with evolution of phosphine which ignites spontaneously in air.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Chemical: Phosphinic acid, potassium salt
Phosphinic acid, potassium salt: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
When strongly heated it decomposes with evolution of phosphine which ignites spontaneously in air.
When heated it evolves phosphine which then ignites in air.
Moderate fire risk ... .
The following chemicals have been specifically designated by the Administrator of the Drug Enforcement Administration as the listed chemicals subject to the provisions of this part and parts 1309 and 1313 of this chapter. Each chemical has been assigned the DEA Chemical Code Number set forth opposite it. Hypophosphorous acid and its salts (Including ammonium hypophosphite, calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite and sodium hypophosphite) (DEA Code Number: 6797) are included on List 1 chemicals.
It explodes when triturated with chlorates or other oxidizing agents.
Explodes on evaporation with /nitric acid/.
... May explode if ground with chlorates, nitrates, or other strong oxidizing agents.
It explodes when triturated with chlorates or other oxidizing agents.
Explodes on evaporation with /nitric acid/.
This is a DEA List 1 chemical substance.
List I chemical means a chemical specifically designated by the Administrator in section 1310.02(a) of this chapter that, in addition to legitimate uses, is used in manufacturing a controlled substance in violation of the Act and is important to the manufacture of a controlled substance.
/Formerly/ used in the preparation of hypophosphites syrup
UsesPotassium hypophosphite is used in medicine as an analytical reagent and oxidizing agent. As a reducing agent, it is applied in pharmaceuticals, food, and electroless plating.
Loading…
Loading…
No reaction records under the current filter.
Loading…
When strongly heated it decomposes with evolution of phosphine which ignites spontaneously in air. It explodes when triturated with chlorates or other oxidizing agents.
Very deliquescent
SRP: Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in air, soil or water; effects on animal, aquatic and plant life; and conformance with environmental and public health regulations. If it is possible or reasonable use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination.
IDENTIFICATION AND USE: Potassium hypophosphite forms white crystals or granular powder. This is a DEA List 1 chemical substance. It was formerly used in the preparation of hypophosphites syrup. HUMAN STUDIES: There are no data available. ANIMAL STUDIES: There are no data available.
By analogy to calcium hypophosphite which has been experimentally determined to be completely disassociated in aqueous solution(1), potassium hypophosphite is expected to be completely disassociated in aqueous solution(SRC). Since ionized salts do not volatilize from water, volatilization from water surfaces is not expected to be an important fate process(SRC).
The calcium and potassium hypophosphites do not appear to be currently used as ingredients in foods as indicated by a survey of the food industry conducted by a National Research Council subcommittee in 1970 and more recent information obtained from industry by the Select Committee(1). They had limited medical use many years ago in tonics and as therapeutic agents but appear to be no longer used for these purposes(1).
/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand-valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR as necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Phosphine and Related Compounds/
/SRP:/ Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . /Phosphine and Related Compounds/
/SRP:/ Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag valve mask device may be beneficial. Consider drug therapy for pulmonary edema ... . Monitor cardiac rhythm and treat arrhythmias if necessary ... . Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors if patient is hypotensive with a normal fluid volume. Watch for signs of fluid overload ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Phosphine and Related Compounds/
/SRP:/ Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on the left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Poisons A and B/
For more Antidote and Emergency Treatment (Complete) data for Potassium hypophosphite (6 total), please visit the HSDB record page.
The following chemicals have been specifically designated by the Administrator of the Drug Enforcement Administration as the listed chemicals subject to the provisions of this part and parts 1309 and 1313 of this chapter. Each chemical has been assigned the DEA Chemical Code Number set forth opposite it. Hypophosphorous acid and its salts (Including ammonium hypophosphite, calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite and sodium hypophosphite) (DEA Code Number: 6797) are included on List 1 chemicals.